Insights

A leaked recording of a speech by China's biggest property developer is sending shockwaves throughout the country's property sector.

The week in clean energy saw more rollercoaster rides for fuel cells, President Hollande weigh in on Alstom and a wave of new wind projects.

The once outrageously priced laptop is now the most affordable laptop Apple has ever sold and there's still room for some improvement.

US stocks close lower as investors fret about the latest outbreak of violence in Ukraine.

Infrastructure investors, investment banks interested in Qld's $2.6bn Wiggins coal port.

Alibaba's decision to list in the US appears to be a loss for China. But there is a possible 'face saving' resolution that could yet see the online retail giant make its homecoming.

A staring contest is developing between the East and West on the Ukraine situation and investors don't like it. Tech stocks also helped push Wall Street lower with Twitter leading the way.

Pfizer's AstraZeneca bid frames Britain as little more than a convenient tax haven, and there are no guarantees the US pharma giant's presence will benefit the public.

The public brawl between James Packer and David Gyngell is another blight on the harbour city, which has been tainted by corruption scandals. It's a serious blow to Australia's global reputation.

Frank Lowy finally gives in to shareholders ahead of a crucial vote for Westfield's restructure, while Woolworths' credit card partnership with HSBC comes to an end.

China bears will likely be waiting for the nation's 'Lehman moment' for some time, but that doesn't mean there aren't deep problems brewing.

There are plenty of policies that could serve as triggers for a double dissolution, if the government thinks it is worth the risk to get its reform agenda through.

Abbott govt cements $4bn company tax cut in budget despite hunt for new savings.

New review to show spending commitments of up to $38bn were locked in under Labor.

A survey of investors by Morgan Stanley reveals UK exit or recovery key to share price boost.

America's largest healthcare company in pole position with $5bn bid for hospital owner.